Perennial Investment Advisors LLC Takes Position in Procter & Gamble Company (The) $PG

Perennial Investment Advisors LLC acquired a new position in Procter & Gamble Company (The) (NYSE:PG) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 4,505 shares of the company’s stock, valued at approximately $661,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of PG. Baxter Bros Inc. purchased a new position in Procter & Gamble in the second quarter worth $12,381,000. Cibc World Market Inc. raised its holdings in Procter & Gamble by 40.6% during the 4th quarter. Cibc World Market Inc. now owns 511,833 shares of the company’s stock valued at $73,351,000 after buying an additional 147,701 shares during the last quarter. World Investment Advisors raised its stake in shares of Procter & Gamble by 15.9% during the fourth quarter. World Investment Advisors now owns 105,915 shares of the company’s stock valued at $15,179,000 after acquiring an additional 14,492 shares during the last quarter. Resources Management Corp CT ADV lifted its holdings in Procter & Gamble by 41.8% in the 4th quarter. Resources Management Corp CT ADV now owns 81,511 shares of the company’s stock worth $11,681,000 after buying an additional 24,010 shares during the period. Finally, Indivisible Partners bought a new stake in Procter & Gamble in the fourth quarter valued at $2,120,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Performance

Procter & Gamble stock opened at $143.71 on Friday. The company’s 50-day moving average price is $147.11 and its 200-day moving average price is $148.28. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25. The company has a market cap of $334.04 billion, a PE ratio of 21.71, a price-to-earnings-growth ratio of 4.43 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last released its earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The firm had revenue of $21.20 billion during the quarter, compared to analyst estimates of $21.38 billion. During the same quarter last year, the business earned $1.48 EPS. The business’s revenue was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, equities research analysts forecast that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 17th. Shareholders of record on Friday, July 24th were issued a dividend of $1.0885 per share. The ex-dividend date was Friday, July 24th. This represents a $4.35 dividend on an annualized basis and a yield of 3.0%. Procter & Gamble’s dividend payout ratio is currently 65.71%.

Wall Street Analysts Forecast Growth

PG has been the topic of several recent research reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research note on Wednesday, June 24th. HSBC reaffirmed a “hold” rating and issued a $149.00 price objective (down from $182.00) on shares of Procter & Gamble in a research report on Thursday, July 30th. Citigroup reduced their price target on shares of Procter & Gamble from $181.00 to $170.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. JPMorgan Chase & Co. cut their price objective on Procter & Gamble from $164.00 to $162.00 and set an “overweight” rating for the company in a report on Thursday, July 16th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating and set a $149.00 target price on shares of Procter & Gamble in a report on Monday, August 24th. Thirteen analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $161.19.

Insider Buying and Selling

In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 359 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $145.24, for a total transaction of $52,141.16. Following the transaction, the chief accounting officer owned 1,271 shares in the company, valued at approximately $184,600.04. This represents a 22.02% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Marc S. Pritchard sold 4,030 shares of the company’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $143.79, for a total value of $579,473.70. Following the completion of the sale, the insider owned 187,001 shares in the company, valued at approximately $26,888,873.79. This represents a 2.11% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 6,627 shares of company stock worth $953,417 in the last three months. 0.20% of the stock is owned by insiders.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.